Wells Fargo & Company Pulse Biosciences, Inc. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 8,362 shares of PLSE stock, worth $143,742. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,362
Previous 7,995
4.59%
Holding current value
$143,742
Previous $69,000
34.78%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding PLSE
# of Institutions
60Shares Held
4.78MCall Options Held
138KPut Options Held
96.2K-
Black Rock Inc. New York, NY1.15MShares$19.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA905KShares$15.6 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC783KShares$13.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA424KShares$7.29 Million0.0% of portfolio
-
State Street Corp Boston, MA392KShares$6.73 Million0.0% of portfolio
About Pulse Biosciences, Inc.
- Ticker PLSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,125,900
- Market Cap $638M
- Description
- Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...